Published June 9, 2010
| Version v1
Journal article
Hyperthermic intra-peritoneal chemotherapy using Oxaliplatin as consolidation therapy for advanced epithelial ovarian carcinoma. Results of a phase II prospective multicentre trial. CHIPOVAC study
Contributors
Others:
- Centre Jean Perrin [Clermont-Ferrand] (UNICANCER/CJP) ; UNICANCER
- Institut Claudius Regaud
- Centre Paul Papin(Angers) ; Centre Paul Papin(Angers)
- Institut Gustave Roussy (IGR)
- Centre René Gauducheau(Nantes) ; Centre René Gauducheau(Nantes)
- Centre de Lutte contre le Cancer Antoine Lacassagne [Nice] (UNICANCER/CAL) ; UNICANCER-Université Côte d'Azur (UCA)
- CRLC Val d'Aurelle-Paul Lamarque ; CRLCC Val d'Aurelle - Paul Lamarque
- Centre Léon Bérard [Lyon]
- Centre Alexis Vautrin (CAV)
Description
The aim of the present study was to prospectively evaluate morbidity of intra-peritoneal hyper-thermic chemotherapy (HIPEC) using Oxaliplatin as consolidation therapy for advanced epithelial ovarian carcinoma and, secondly, to study peritoneal recurrence.
Abstract
Presented at the 16th International Meeting of the European Society for Gynaecological Oncology (ESGO 16) Belgrade, Serbia, October 11–14, 2009.Abstract
International audienceAdditional details
Identifiers
- URL
- https://hal.archives-ouvertes.fr/hal-00599226
- URN
- urn:oai:HAL:hal-00599226v1
Origin repository
- Origin repository
- UNICA